Whereas miR-221 overexpressing LNCaP cells showed a trend towards higher cell viability ( p = 0.054), the comparison between TRAIL-treated LNCaP cells after pre-miR-221 or control transfections was statistically significant (119.5 ± 19.7% vs. 84.8 ± 5.6%, p = 0.013).
Compared to the control group, the meditation group showed a trend of reductions in the Menopausal Rating Scale total score ( P = .054) and its 2 subcomponents: depressive mood ( P = .064) and irritability ( P = .061).
Treatment eyes (T) in older children also showed a trend towards decline in MP and ALE with progressive age (r = − 0.38, p = 0.054; r = 0.39, p = 0.052 respectively; Fig. 3 c,d).
Interestingly, testosterone showed a trend to increase power in the beta band ( p = 0.054) and did in the gamma band ( p = 0.045).
Morphology of the Colon and Frequency of Goblet Cells, Intraepithelial Lymphocytes and IgA-Positive Cells Colon tissue from Gln-supplemented piglets had a higher number of CD3 + IELs ( p = 0.028) and showed a trend for an increase in the lamina propria ( p = 0.054) ( Table 1 ).
Although FDG-PET avidity did not reach statistical significance in the multivariate model, it showed a trend toward worse survival ( p = 0.054).
Of note, increased EBRT treatment length also showed a trend toward statistical significance (OR 0.965, 95% CI 0.931–1.001, p = 0.054). 3.3.
The HbO 2 triggered by real spTMS after cTBS showed a trend to be significantly higher than the ones pre-TBS (mean difference = 6.19%, SE = 3.21, p = 0.054), but there was no significant difference between pre-TBS and after iTBS (mean difference = -3.61%, SE = 3.21, p = 0.26).
HD showed a trend of association with elevated WBC counts in AML (P = 0.054).
Asymmetry in constriction velocity showed a trend with Evans index (ρ = 0.49, n = 16, p = 0.054, q = 0.161).
Moreover, splenomegaly showed a trend to significance with LC [OR 2.72 (95% CI 0.98, 7.54); p = 0.054].
Moreover, the same cluster also showed a trend for a correlation with empathy skills measured by BEES scores (Spearman r = 0.34, P = 0.054).
Nontreosulfan-based MAC showed a trend toward increased mortality compared with RIC (HR, 4.0; 95% CI, 1.0-16.2; P = .054).
In multivariate analysis, having 2 or more positive CBCL subscales showed a trend toward association with poor glycemic control (adjusted odds ratio=21.47, p =0.054).
However, we also tried analyzing a multivariate regression equation model using the dichotomized NCCN‐IPIs (divided into two groups of low/low‐intermediate and high‐intermediate/high‐risk groups) and concluded that TLG 0 , TLG 1 , and the dichotomized NCCN‐IPIs showed predictive value independently (HR = 5.839, 95% CI 1.20‐28.44, P ‐value = 0.029; HR = 3.082, 95% CI 1.15‐8.25, P = 0.025; HR = 3.00, 95% CI 1.08‐8.33, P = 0.035, respectively) (Table S2 ), whereas that of %ΔSUV max in this model showed a trend for significance as an independent predictor of PFS (HR = 3.80, 95% CI 0.98‐14.77, P ‐value = 0.054).
Instead, the levels showed a trend toward reduction (p = 0.054), suggesting that demand for serine as a 1C donor may be increased.
Similarly, guselkumab showed a trend towards superiority over adalimumab for hands and/or feet psoriasis (82.9% vs. 61.5%, p = 0.054).
The non‐dominant‐hand PPT score increased significantly in sham participants (from 15·2(2·1) at baseline to 16·3(2·1) post‐training; P = 0·002), and the dominant‐hand PPT score showed a trend towards an increase (from 17·0(1·8) to 17·5(1·8); P = 0·054).
Sex as a variable did not have a significant effect on either lesion size or tissue loss, although saline-treated females showed a trend to a smaller ventricular enlargement, and hence lesser tissue loss, when compared to saline-treated males ( p = 0.054).
Most women (83.8%) reported no regular physical activity during pregnancy and family history of obesity, diabetes mellitus, hypertension, thyroid disorders and polycystic ovary syndrome were noted in 40.4%, 23.4%, 17.1%, 19.1% and 15%, respectively. In the antepartum period, rates of gestational diabetes mellitus, gestational hypertension and anemia did not differ significantly between women with BMI 30-32 kg/m 2 and those with BMI > 32 kg/m 2 (all p > 0.05), whereas severe preeclampsia showed a trend toward higher prevalence in the BMI > 32 kg/m 2 group (20.8% vs. 7.1%, p = 0.054) (Table 1 - see PDF).
For BrdU and NeuN double labeling, Ngf cKO mice also showed a trend for lower level of BrdU+/NeuN+ cell number ( p = 0.054, t (14) = 2.09) (Fig. 1C ).
SF-1 followed a similar trend, although the changes showed a trend to significance ( p < 0.054).
Although not statistically significant, axi-cel showed a trend toward an improvement in OS, with a median OS not reached (NR) versus 35.1 months for axi-cel and SOC, respectively (HR, 0.73; 95% CI, 0.53–1.01; p = 0.054), and 2-year OS was 61% for axi-cel versus 52% for SOC, with longer follow-up time needed.
Tolterodine had no effect at lower doses (0.3 or 0.1 mg/kg), but showed a trend for impaired learning at the highest dose (1 mg/kg; p = 0.054 for the reduction in latency), although this represents 100× the doses of tolterodine required to affect bladder contractions (assessed as inhibition of carbachol-induced increase in intravesical pressure).
Although the intergroup comparison revealed no significant group differences, the direct comparison of steroid-sensitive and steroid-refractory samples showed a trend towards higher CD4 + CD25 + CD127 low T reg repertoire diversity ( p = 0.054; CD4 + T con , p = 0.114) linked to steroid sensitivity.